FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.50), $0.01 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $31.93 million versus the consensus estimate of $27.15 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.